Cyclerion Therapeutics, Inc. (CYCN)


Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cyclerion Therapeutics, Inc. chart...

About the Company

We do not have any company description for Cyclerion Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

35

Exchange

Nasdaq

$0M

Total Revenue

35

Employees

$8M

Market Capitalization

-4.39

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CYCN News

Cyclerion Therapeutics Inc Ordinary Shares CYCN

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Cyclerion Therapeutics (NASDAQ: CYCN)

8d ago, source: The Motley Fool

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes ...

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

20d ago, source: Hosted on MSN

Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quarter of 2023. Cyclerion Therapeutics reported earnings per share of -$1.60. The company did not report any revenue for ...

12 Best Biotech Penny Stocks to Invest In

1mon ago, source: InvestingChannel on MSN

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) is a Boston-based biopharma firm founded in 2018. Cyclerion Therapeutics, Inc.

DiaMedica Therapeutics Inc. (DMAC)

6d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

FULC Fulcrum Therapeutics, Inc.

1d ago, source: Seeking Alpha

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high ...

Cyclerion Therapeutics Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...